Soleno Therapeutics (SLNO) Insider Trading & Ownership $44.14 -1.66 (-3.61%) As of 11:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Soleno Therapeutics (NASDAQ:SLNO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage12.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$76.10 M Get SLNO Insider Trade Alerts Want to know when executives and insiders are buying or selling Soleno Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SLNO Insider Buying and Selling by Quarter Soleno Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/3/2025Kristen YenInsiderSell2,340$46.18$108,061.20 1/2/2025Bhatnagar AnishCEOSell10,937$45.41$496,649.17 1/2/2025James H MackanessCFOSell4,083$45.41$185,409.03 10/1/2024Bhatnagar AnishCEOSell21,633$49.43$1,069,319.19 10/1/2024James H MackanessCFOSell8,077$49.43$399,246.11 10/1/2024Kristen YenInsiderSell3,108$49.43$153,628.44 8/29/2024Vivo Opportunity, LlcMajor ShareholderSell100,000$47.22$4,722,000.00 8/28/2024Bhatnagar AnishCEOSell56,613$47.58$2,693,646.54 8/28/2024James H MackanessCFOSell6,661$47.58$316,930.38 8/28/2024Kristen YenInsiderSell5,270$47.58$250,746.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/27/2024Vivo Opportunity, LlcMajor ShareholderSell500,000$48.73$24,365,000.00 8/5/2024Bhatnagar AnishCEOSell58,213$45.77$2,664,409.01 8/5/2024James H MackanessCFOSell6,849$45.77$313,478.73 8/5/2024Kristen YenInsiderSell5,017$45.77$229,628.09 7/1/2024Bhatnagar AnishCEOSell19,256$41.54$799,894.24 7/1/2024James H MackanessCFOSell7,190$41.54$298,672.60 7/1/2024Kristen YenInsiderSell2,170$41.54$90,141.80 4/29/2024Vivo Opportunity, LlcMajor ShareholderSell750,000$47.80$35,850,000.00 4/1/2024Bhatnagar AnishCEOSell18,980$41.34$784,633.20 4/1/2024James H MackanessCFOSell5,175$41.34$213,934.50 4/1/2024Kristen YenInsiderSell2,218$41.34$91,692.12 (Data available from 1/1/2013 forward) SLNO Insider Trading Activity - Frequently Asked Questions Who is on Soleno Therapeutics's Insider Roster? The list of insiders at Soleno Therapeutics includes Bhatnagar Anish, Jack W Schuler, James H Mackaness, Kristen Yen, Perceptive Advisors Llc, and Vivo Opportunity, Llc. Learn more on insiders at SLNO. What percentage of Soleno Therapeutics stock is owned by insiders? 12.30% of Soleno Therapeutics stock is owned by insiders. Learn more on SLNO's insider holdings. Which Soleno Therapeutics insiders have been buying company stock? The following insider purchased SLNO shares in the last 24 months: Perceptive Advisors Llc ($16,231,728.24). How much insider buying is happening at Soleno Therapeutics? Insiders have purchased a total of 1,070,257 SLNO shares in the last 24 months for a total of $16,231,728.24 bought. Which Soleno Therapeutics insiders have been selling company stock? The following insiders have sold SLNO shares in the last 24 months: Bhatnagar Anish ($13,452,919.57), James H Mackaness ($3,135,441.23), Kristen Yen ($1,730,317.08), and Vivo Opportunity, Llc ($64,937,000.00). How much insider selling is happening at Soleno Therapeutics? Insiders have sold a total of 1,805,957 Soleno Therapeutics shares in the last 24 months for a total of $83,255,677.88 sold. Soleno Therapeutics Key ExecutivesDr. Anish Bhatnagar M.D. (Age 54)President, CEO, COO & Director Compensation: $1.06MMr. James H. MacKaness (Age 60)Chief Financial Officer Compensation: $640k2 recent tradesMs. Patricia C. Hirano M.P.H. (Age 58)Senior Vice President of Regulatory Affairs Compensation: $493kMs. Lauren BudesheimVice President of PeopleMs. Kristen Yen M.S. (Age 55)Senior Vice President of Clinical Operations Compensation: $317.19k2 recent tradesDr. Neil M. Cowen M.B.A.Ph.D., Senior Vice President of Drug DevelopmentMs. Meredith Manning M.B.A. (Age 52)Chief Commercial Officer Dr. Michael Huang M.D. (Age 50)Senior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies GKOS Insider Transactions BLCO Insider Transactions INSP Insider Transactions NARI Insider Transactions IRTC Insider Transactions NVST Insider Transactions PRCT Insider Transactions LIVN Insider Transactions TMDX Insider Transactions ENOV Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:SLNO) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLNO Stock Alerts